Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

M. De Santis, J. Bellmunt, G. Mead, J.M. Kerst, Michael Leahy, P. Maroto, T. Gil, S. Marreaud, G. Daugaard, I. Skoneczna, S. Collette, J. Lorent, R. De Wit, R. Sylvester

    Research output: Contribution to journalReview article

    314 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)191-199
    JournalJournal of Clinical Oncology
    Volume30
    Issue number2
    DOIs
    Publication statusPublished - 2012

    Cite this

    De Santis, M., Bellmunt, J., Mead, G., Kerst, J. M., Leahy, M., Maroto, P., Gil, T., Marreaud, S., Daugaard, G., Skoneczna, I., Collette, S., Lorent, J., De Wit, R., & Sylvester, R. (2012). Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. Journal of Clinical Oncology, 30(2), 191-199. https://doi.org/10.1200/JCO.2011.37.3571